Acorn Bioventures, L.P.

13F Holdings History for Candel Therapeutics, Inc. - Common stock, par value $0.0001 per share (CADL)

Symbol: CADL on Nasdaq
Investment type: Equity / Common stock, par value $0.0001 per share
Latest Disclosed Ownership: 2.58M shares
Security Ownership: 5.2%

Anders Hove ownership in Candel Therapeutics, Inc. Common stock, par value $0.0001 per share (CADL)

2025-06-30 - Anders Hove has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.58M shares of Candel Therapeutics, Inc. Common stock, par value $0.0001 per share (CADL). This represents 5.2% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Anders Hove	5.2%		$12.4M	2.58M			$4.81	13G	6/25/2025	30 Jun 2025 09:55:23